NCT05194579View on ClinicalTrials.gov

Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe

PHASE1CompletedINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

August 10, 2022

Study Completion Date

August 10, 2022

Conditions
Healthy Volunteers
Interventions
COMBINATION_PRODUCT

PF-06881894 by on-body injector

PF-06881894 given by on-body injector (OBI), 6 mg administered as a single SC injection

COMBINATION_PRODUCT

PF-06881894 by prefilled syringe

PF-06881894 given by prefilled syringe (PFS), 6 mg administered as a single SC injection

Trial Locations (4)

33024

Research Centers of America ( Hollywood ), Hollywood

55114

Prism Research LLC dba Nucleus Network, Saint Paul

78229

Clinical Trials of Texas, LLC, San Antonio

92801

Anaheim Clinical Trials, LLC, Anaheim

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05194579 - Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe | Biotech Hunter | Biotech Hunter